Purpose: [(18)F]ML-10 is the most advanced radiopharmaceutical for the clinical imaging of the apoptosis phenomenon by PET. The preparation of this radiopharmaceutical on a commercial radiosynthesis module and the requested quality controls for its release are presented herein.
Procedures: ML-10 as reference and its mesyloxy derivative as precursor for labelling with fluorine-18 were prepared.